IBDEI0LC ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10460,1,5,0)
 ;;=5^Hallucinations
 ;;^UTILITY(U,$J,358.3,10460,2)
 ;;=Hallucinations^53738
 ;;^UTILITY(U,$J,358.3,10461,0)
 ;;=780.8^^67^678^87
 ;;^UTILITY(U,$J,358.3,10461,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10461,1,4,0)
 ;;=4^780.8
 ;;^UTILITY(U,$J,358.3,10461,1,5,0)
 ;;=5^Hyperhidrosis
 ;;^UTILITY(U,$J,358.3,10461,2)
 ;;=Hyperhidrosis^60030
 ;;^UTILITY(U,$J,358.3,10462,0)
 ;;=307.41^^67^678^99
 ;;^UTILITY(U,$J,358.3,10462,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10462,1,4,0)
 ;;=4^307.41
 ;;^UTILITY(U,$J,358.3,10462,1,5,0)
 ;;=5^Insomnia, Nonorganic, Transient
 ;;^UTILITY(U,$J,358.3,10462,2)
 ;;=^268285
 ;;^UTILITY(U,$J,358.3,10463,0)
 ;;=780.52^^67^678^100
 ;;^UTILITY(U,$J,358.3,10463,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10463,1,4,0)
 ;;=4^780.52
 ;;^UTILITY(U,$J,358.3,10463,1,5,0)
 ;;=5^Insomnia, Organic
 ;;^UTILITY(U,$J,358.3,10463,2)
 ;;=Insomnia, Organic^87662
 ;;^UTILITY(U,$J,358.3,10464,0)
 ;;=302.71^^67^678^103
 ;;^UTILITY(U,$J,358.3,10464,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10464,1,4,0)
 ;;=4^302.71
 ;;^UTILITY(U,$J,358.3,10464,1,5,0)
 ;;=5^Loss of Libido
 ;;^UTILITY(U,$J,358.3,10464,2)
 ;;=^268178
 ;;^UTILITY(U,$J,358.3,10465,0)
 ;;=785.6^^67^678^106
 ;;^UTILITY(U,$J,358.3,10465,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10465,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,10465,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,10465,2)
 ;;=Lymphadenopathy^72368
 ;;^UTILITY(U,$J,358.3,10466,0)
 ;;=728.85^^67^678^112
 ;;^UTILITY(U,$J,358.3,10466,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10466,1,4,0)
 ;;=4^728.85
 ;;^UTILITY(U,$J,358.3,10466,1,5,0)
 ;;=5^Muscle Spasm
 ;;^UTILITY(U,$J,358.3,10466,2)
 ;;=Muscle Spasm^112558
 ;;^UTILITY(U,$J,358.3,10467,0)
 ;;=782.0^^67^678^51
 ;;^UTILITY(U,$J,358.3,10467,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10467,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,10467,1,5,0)
 ;;=5^Disturbance of Skin Sensation
 ;;^UTILITY(U,$J,358.3,10467,2)
 ;;=Disturbance of Skin Sensation^35757
 ;;^UTILITY(U,$J,358.3,10468,0)
 ;;=278.00^^67^678^117
 ;;^UTILITY(U,$J,358.3,10468,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10468,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,10468,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,10468,2)
 ;;=Obesity^84823
 ;;^UTILITY(U,$J,358.3,10469,0)
 ;;=278.01^^67^678^118
 ;;^UTILITY(U,$J,358.3,10469,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10469,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,10469,1,5,0)
 ;;=5^Obesity, Morbid
 ;;^UTILITY(U,$J,358.3,10469,2)
 ;;=Obesity, Morbid^84844
 ;;^UTILITY(U,$J,358.3,10470,0)
 ;;=783.5^^67^678^127
 ;;^UTILITY(U,$J,358.3,10470,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10470,1,4,0)
 ;;=4^783.5
 ;;^UTILITY(U,$J,358.3,10470,1,5,0)
 ;;=5^Polydipsia
 ;;^UTILITY(U,$J,358.3,10470,2)
 ;;=Polydipsia^186699
 ;;^UTILITY(U,$J,358.3,10471,0)
 ;;=783.6^^67^678^128
 ;;^UTILITY(U,$J,358.3,10471,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10471,1,4,0)
 ;;=4^783.6
 ;;^UTILITY(U,$J,358.3,10471,1,5,0)
 ;;=5^Polyphagia
 ;;^UTILITY(U,$J,358.3,10471,2)
 ;;=Polyphagia^60236
 ;;^UTILITY(U,$J,358.3,10472,0)
 ;;=780.2^^67^678^144
 ;;^UTILITY(U,$J,358.3,10472,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10472,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,10472,1,5,0)
 ;;=5^Syncope and Collapse
 ;;^UTILITY(U,$J,358.3,10472,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,10473,0)
 ;;=783.1^^67^678^156
 ;;^UTILITY(U,$J,358.3,10473,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10473,1,4,0)
 ;;=4^783.1
 ;;^UTILITY(U,$J,358.3,10473,1,5,0)
 ;;=5^Weight gain, abnormal
 ;;^UTILITY(U,$J,358.3,10473,2)
 ;;=^998
